Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Toxoplasma gondii calcium-dependent protein kinase 3 (TgCDPK3) is a key regulator of the lytic cycle in the protozoan parasite Toxoplasma gondii, the causative agent of toxoplasmosis (Lourido et al., 2012, Science). It acts as a calcium-responsive switch that triggers the rapid egress of parasites from host cells and facilitates gliding motility, both of which are essential for the dissemination of the infection (McCoy et al., 2012, Science). Since calcium-dependent protein kinases (CDPKs) are found in apicomplexan parasites but are absent in mammals, TgCDPK3 serves as a highly selective therapeutic target (Sibley et al., 2013, Nature Reviews Microbiology). Small molecule inhibitors known as bumped kinase inhibitors (BKIs), such as BKI-1294, have been developed to exploit the unique architecture of the TgCDPK3 ATP-binding pocket, which contains a small glycine gatekeeper residue (Ojo et al., 2014, J Infect Dis). Inhibition of TgCDPK3 effectively traps the parasite within the host cell, preventing further tissue damage and disease progression.
Inhibition of kinase activity by competitive binding to the ATP-binding site, specifically exploiting the small gatekeeper residue (Glycine 128) to achieve selectivity over host kinases (Ojo et al., 2014, J Infect Dis).
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Toxoplasma gondii calcium-dependent protein kinase 3 (TgCDPK3) (TgCDPK3).